AI-Powered Platform Automates High-Converting Pages to Capture Competitor Traffic and Dominate Search Results

SINGAPORE, Sept. 12, 2025 /PRNewswire/ — In a digital landscape where traditional SEO tools overwhelm marketers with data and deliver inconsistent results, SEOPage.ai unveils its game-changing AI Agent. This autonomous platform transforms strategic traffic acquisition by automating the creation, optimization, and maintenance of SEO-optimized pages designed to intercept competitor traffic and target high-value industry keywords. Tailored for both Google and generative AI search engines, SEOPage.ai empowers businesses to scale their digital presence, rank faster, and drive measurable revenue growth.

Founded in 2025 by seasoned SEO experts and digital marketers, SEOPage.ai builds on the success of its predecessor, AltPage.ai—named Product Hunt’s Product of the Day on May 25, 2025—to deliver a fully autonomous AI Agent experience. This release marks a leap forward, with an intelligent system that audits competitors, drafts dynamic sitemaps, and generates pages while users focus on strategy. By monitoring SERP changes, price updates, and feature shifts in real-time, the AI Agent ensures content stays evergreen, auto-refreshing only what’s needed to maintain a competitive edge.

“SEOPage.ai’s AI Agent is more than a tool—it’s an autonomous SEO marketer that drives growth 24/7,” says Joey Z., Product Owner and Co-Founder. “Built from our years in the SEO trenches, it automates complex strategies to make elite traffic acquisition accessible to all. We’re starting with five high-impact page types and plan to scale to over 100, enabling businesses to dominate every corner of search.”

Autonomous SEO at Scale with the AI Agent

Traditional SEO demands time-intensive research and uncertain outcomes. SEOPage.ai’s AI Agent eliminates these hurdles by leveraging advanced machine learning to analyze user sites, dissect competitors, and identify high-potential opportunities aligned with search intent. It generates complete, ready-to-publish pages infused with structured data, conversational snippets, and citation-ready elements optimized for AI Overviews, People Also Ask (PAA) features, and voice search.

The AI Agent’s core capabilities include:

• Real-Time Competitor Analysis: Pinpoints rival weaknesses across features, pricing, and keywords to target traffic interception opportunities.
• Dynamic Sitemap Planning: Generates intelligent site architectures with prioritized task lists, syncing seamlessly with project management tools.
• Proactive Content Maintenance: Tracks external changes (e.g., SERP shifts, product updates) and auto-updates pages to sustain rankings.
• Enhanced Discoverability: Embeds schema markup, internal linking, and AI-optimized snippets for visibility across traditional and generative search.

Early adopters report 93.8% of generated pages indexed by Google, with traffic gains within weeks and up to 3.2x higher rankings compared to manual efforts. This autonomous approach captures competitor traffic while positioning brands as trusted authorities in an AI-evolving search ecosystem.

Five High-Impact Page Types for Immediate ROI

SEOPage.ai’s AI Agent currently supports five specialized page types, each backed by over 100 customizable templates and proven to drive conversions. These formats target key user intents—comparison, research, and problem-solving—delivering faster results and higher ROI than generic content tools. The platform’s targeted methodology ensures pages resonate with both human searchers and AI algorithms.

The five page types include:

• Alternative Pages: Analyzes competitors to create pages that siphon keyword traffic, positioning your offerings as superior. Ideal for decision-stage users, these drive conversions by highlighting competitive advantages.
• Best Pages: Compares 10+ competitors across dimensions like pricing, features, and reviews. These authoritative hubs attract research-phase traffic and boost topical relevance for AI recommendations.
• FAQ Pages: Targets pain points and emerging queries with schema-optimized, conversational content. Optimized for PAA, voice search, and generative AI, these enhance discoverability and engagement.
• Solution Pages: Develops industry-specific solution overviews, including migration guides and implementation checklists, to address targeted business challenges. These pages capture solution-seeking traffic, demonstrating tailored value propositions and integrating savings calculators to accelerate decision-making.
• Testimonial Pages: Compiles curated customer success stories and testimonials into dedicated hubs, optimized for social proof and trust-building. These pages leverage user-generated content to enhance credibility, improve E-E-A-T signals, and convert skeptical visitors by showcasing real-world results and case studies.

Looking ahead, SEOPage.ai plans to expand to over 100 page types, including glossaries, benchmarks, case studies, and local service pages, enabling comprehensive SEO strategies across industries. This roadmap ensures users stay ahead of search trends with innovative, data-driven formats.

Seamless Automation and Effortless Integration

SEOPage.ai’s AI Agent eliminates technical barriers, delivering a fully automated, end-to-end SEO solution that requires no expertise. From intelligent sitemap design and content creation to coding, publishing, and continuous maintenance, users simply provide their site details, and the AI Agent delivers ready-to-use HTML or markdown files compatible with any website framework. It integrates with analytics tools like Google Analytics, Search Console, and third-party platforms such as Semrush for enhanced insights.Intuitive, real-time dashboards deliver clear metrics on traffic, conversions, search rankings, and ROI, with proactive alerts highlighting optimization opportunities. The free trial includes hosting for up to five pages, while professional tiers scale to support 50 pages with advanced features like priority content generation and auto-updates.

Users rave about the results:

“SEOPage.ai is like having a dedicated SEO strategist in your pocket, streamlining planning and execution,” says Alexis, Chief SEO Strategist.

Jimmy Bartney, Product Manager at Picko Lab, echoes, “It’s a transformative tool that turns data into actionable wins with unmatched efficiency.”

Accessible Pricing for Scalable Growth

SEOPage.ai democratizes advanced SEO with flexible plans:

• Free Trial: $0/month, 50 credits (~5 pages), hosting for 5 pages, standard support.
• Standard: $29.9/month, 300 credits (~30 pages), hosting for 30 pages.
• Professional: $49.90/month, 500 credits (~50 pages), priority generation and support.

These tiers cater to startups and enterprises alike, with custom options for high-volume needs. By focusing on high-ROI pages, the AI Agent maximizes impact and minimizes waste.

About SEOPage.ai

Developed in-house by eclicktech, SEOPage.ai is the world’s first SEO AI Agent, currently led by Joey Z., whose expertise in AI-driven SEO fuels the platform’s mission to make sophisticated strategies accessible. Building on AltPage.ai’s Product Hunt success, SEOPage.ai has earned buzz on X and Product Hunt for its efficiency in competitive content generation. The team’s goal is clear: empower every business to claim valuable search traffic, regardless of resources.

For more details, visit https://seopage.ai. Media inquiries: Joey Z. at +1 307-533-5946 or joey@seopage.ai. 

Contact Information:
SEOPage.ai 
Singapore
Contact: Joey Z., Product Owner
Phone: +1 307-533-5946
Email: joey@seopage.ai 

MONTREAL, Sept. 12, 2025 /PRNewswire/ — A concerted effort by the World Federation of Hemophilia (WFH) and its partners has led to the World Health Organization (WHO) updating its Essential Medicines List (EML) and the Essential Medicines List for Children (EMLc) to better align the EMLs to the international clinical guidelines for the management of hemophilia and von Willebrand Disease (VWD). These revisions will have a positive impact on lives of people with bleeding disorders (PWBDs) everywhere.

The WHO EML has a critical role in guiding national governments on the selection and financing of essential medicines for a range of conditions, including hemophilia. These revisions mean that decision makers will be using up-to-date recommendations when making key decisions that will impact treatment for people with hemophilia.

“The updates to the WHO EML mean that thousands of PWBDs now have greater hope for a better future. The WFH is proud to have led a united global effort to make this milestone possible. Together, we are shaping a future where our vision of Treatment for All can become a reality.”
—Cesar Garrido, President, WFH

The request to update the WHO EML was built on key revisions that were needed to improve listings for the treatment of hemophilia and VWD. Today, prophylaxis is the internationally recognized standard of care for people with hemophilia. A range of virally safe and effective therapies are available for people with hemophilia and VWD. Conversely, cryoprecipitate (whether pathogen-reduced, PR-Cryo, or not) cannot be used for prophylaxis. Furthermore, cryoprecipitate poses a significant risk of transmission of bloodborne infections.  

The revisions introduced in the recently published 24th EML and 10th EMLc will help to increase equitable access to safer and more effective therapies for PWBDs worldwide. Outlined below are the critical changes made to the EML and EMLc, in relation to the medicines indicated for treatment of hemophilia and VWD.  

New medicines added to the EML and EMLc

• Bi-specific monoclonal antibody, emicizumab, was included on the core list
• Recombinant FVIII and FIX clotting factor concentrates (CFCs) was included on the core list

Revisions made to existing medicines listed on EML and EMLc

• Plasma-derived FVIII and FIX CFCs were transferred from the complementary to the core list
• Desmopressin was transferred from the complementary to the core list

Medicines or formulations deleted on EML and EMLc

• Both pathogen-reduced and non-pathogen reduced cryoprecipitate were removed as indications for the treatment of hemophilia and VWD
• Factor IX Complex (also known as prothrombin complex concentrate (PCC)) was deleted as a therapeutic alternative to FIX CFCs

“The WHO’s decision to update the Essential Medicines Lists marks a major step forward in ensuring access to modern, effective treatments for people with bleeding disorders worldwide. This milestone was only possible thanks to the strong support and collaboration of scientific and patient advocacy organizations across the world. Together, we have helped align global policy with the best clinical standards, making the EML a strong advocacy tool to countless patients and families in countries that don’t have full access to these therapies.”
—Glenn Pierce, MD, PhD, Vice President, Medical, WFH

This milestone for our community was realized thanks to a joint effort led by the WFH, underscoring the wide-reaching commitment across institutions, experts, and organizations to update the EML.

The process included the WFH undertaking a two-year-long ongoing direct dialogue with the WHO Headquarters and consulting with the EML Secretariat closely throughout the application process. The WFH was also an active participant at the meeting of the WHO 25th Expert Committee on the Selection and Use of Essential Medicines, and made a statement in favour of updating the guidelines during the public session on May 5, 2025.

The WFH also summarized its concerns about the outdated recommendations in “Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List” published in The Lancet Haematology in September 2024.

The WFH would like to acknowledge and express its gratitude to its national member organizations (NMOs), expert clinicians, hemophilia treatment centres (HTCs) and scientific and patient advocacy associations from around the globe that supported this endeavour. A joint letter of support addressing the WHO Director General was endorsed by 115 WFH NMOs, while another was signed by over 120 expert clinicians representing every region of the world. Additional individual letters of support came from leading medical and patient associations, including the European Association for Haemophilia and Allied Disorders (EAHAD), the European Haemophilia Consortium (EHC), the International Society on Thrombosis and Haemostasis (ISTH), the Association for Haemophilia and Allied Disorders – Asia Pacific (AHAD-AP), Grupo Cooperativo Latinoamericano de Hemostasia y Trombosis (CLAHT), the Association for the Advancement of Blood and Biotherapies (AABB), the Indian Association for Haemophilia and Allied Disorders (IAHAD), the International Patient Organization for Primary Immunodeficiencies (IPOPI), Rare Diseases International (RDI), the Plasma Protein Therapeutics Association (PPTA), the International Plasma and Fractionation Association (IPFA), the Cerus Corporation, and other organizations.

This wealth of support from our NMOs, expert clinicians, partners and collaborating scientific and patient associations is a true testament of how our global bleeding disorders community can come together for a common cause and in service of our shared vision of Treatment for All.

The three WFH submissions for the 2025 update of EML and EMLc, respective letters of support and the WFH Statement made at the meeting of the WHO 25th Expert Committee on the Selection and Use of Essential Medicines can be viewed here.

To view the WFH publication on “Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List” published in The Lancet Haematology, please click here.

To view the recently-published 24^th Essential Medicines List and the 10^th Essential Medicines List for Children of the World Health Organization (WHO), please click here.

About hemophilia and other bleeding disorders

In people with bleeding disorders, the blood clotting process doesn’t work properly, with the result that they can bleed for longer than normal, and some people may experience spontaneous bleeding into joints, muscles, internal organs or other parts of their bodies which can lead to serious health complications and even be fatal if left untreated.

About the World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is a non-profit organization dedicated to improving and sustaining care for people with inherited bleeding disorders around the world. At the WFH, national member organizations (NMOs) and health care professionals (HCPs) work together to provide care for people with inherited bleeding disorders around the world. We partner with governments and hemophilia treatment centres to enhance knowledge through training and provide tools they need to identify, support, and treat people living with bleeding disorders in their communities, while promoting global advocacy and collaboration to achieve our common goals. The WFH is founded upon the following core values and organizational principles: patients first, collaboration, integrity, respect, solidarity and excellence. 

Our vision of Treatment for All is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, or where they live. Our mission is to improve and sustain care for people with inherited bleeding disorders around the world. 

To find out more about the WFH, please visit  www.wfh.org. 

Media contact:

Neha Suchak 
Director, Marketing & Communications 
nsuchak@wfh.org  
+1 514-875-7944, #2857 
www.wfh.org

MUNICH, Sept. 12, 2025 /PRNewswire/ — AAC Technologies debuted at IAA Mobility in Munich under the theme “The Future of Sound in Motion”. Alongside PSS, First Light Auto Parts, and PSG, AAC Technologies showcased its full-stack capabilities in automotive acoustics, haptics, optics, perception interaction, and motor systems, highlighting the innovative strength of China’s smart vehicle supply chain.

Since entering the automotive acoustics market in 2018, AAC has achieved vertical integration through strategic acquisitions, establishing a complete acoustic ecosystem spanning “sensing–processing–output”. Combined with its deep technical expertise in acoustics, AAC has become one of the few full-stack automotive acoustic solution providers capable of delivering hardware, software, algorithms, and fine tuning.

At the exhibition, AAC showcased its five core technology segments, including its full-stack acoustic solutions, attracting a large number of visitors to stop and explore. Representatives from many globally renowned automakers—including Audi, BMW, Porsche, Changan Automobile, Volkswagen, Zeekr, Maruti Suzuki, Mercedes-Benz, and Skoda—as well as top audio partners such as Bose, Devialet, Harman, and Meridian also visited the booth for in-depth discussions with the AAC team. The brands experienced the latest automotive solutions and expressed strong interest in exploring more collaboration opportunities in the future.

AAC Technologies ranks among the world’s top ten passenger car audio suppliers and is the only Chinese company on the list. This position is backed by consistent annual R&D investment of 7–10% of revenue, a global network of R&D and manufacturing sites across 19 countries and regions, and over 18,000 patent applications.  Sustained investment in innovation has solidified the group’s technological leadership and business expansion, contributing to its recognition as one of the “Top 100 Global Innovators.”

AAC Technologies highlighted the luxury Zeekr 9X SUV, co-developed with British luxury audio brand Naim Audio. As a technical partner, AAC collaborated with Naim to create a bespoke 9.2.4.8 multidimensional immersive sound system for the vehicle, incorporating 32 speakers and 8 seat shakers. The system uses an industry-leading 40-channel independent amplifier with a peak power of 3868W. This premium setup delivers a fully dimensional surround sound field in the cabin. With exclusive listening modes, users enjoy an elevated auditory experience — from 2D high-fidelity to 3D surround and 4D immersion.

At its Munich exhibit, AAC showcased its “Physical AI”-driven full-stack automotive acoustic solutions, highlighting real-world applications such as the Zeekr 9X that demonstrate the sensory impact of “AAC inside.” Supported by refined customer profiling, the company’s auto sector revenue grew 13% year-on-year to RMB 1.74 billion in the 2025 interim report, emerging as a major growth driver.

With the maturation of the group’s integrated acoustic system capabilities spanning consumer electronics module expertise and automotive application with a closed loop from sound sensing to playback, AAC continues to support its subsidiaries such as First Light Auto Parts and PSG in accelerating overseas market expansion while delivering highly customized, immersive, safer, more human0centric and intelligent driving and riding experiences.

Two-tiered system enables personalized creativity and limitless customization of your lighting — powered by AI

LOS ANGELES, Sept. 12, 2025 /PRNewswire/ — Linkind has launched an all-new AI-driven feature within the AiDot app, offering users an innovative new way to create personalized lighting experiences. Whether you’re setting the mood for a quiet evening or planning a fully synchronized light show, the new system makes it easier than ever to bring your vision to life — with nothing more than a prompt.

The new feature introduces two levels of creative control:

Dotis — Your AI Light Effect Assistant
 Designed for all users, this in-app AI tool makes it easy to access dynamic light displays by simply describing the vibe you want. Using a custom-trained dataset, the app intelligently matches prompts — like “romantic dinner,” “gaming mode,” or “sunset beach vibes” — to a curated library of preset light shows. Each match includes variations in color, speed, rhythm, and effect style, delivering a fast, fun, and frictionless way to light up your space with personality.

Dotis+ — Advanced AI Light Show Creation
 For users who want limitless creative freedom, Dotis+ takes smart lighting to the next level with an exclusive ChatGPT-powered engine. This first-of-its-kind integration transforms simple prompts — “make it feel like a midnight city drive” or “energize my workout” — into entirely unique light shows. No presets. No boundaries. Dotis+ combines ChatGPT’s coding intelligence with Linkind’s Lua-based light effect algorithm to generate original patterns, colors, speeds, and rhythms in real time. The result: your imagination, translated into light with unmatched precision and personality.

“We’re always looking for ways to make smart lighting more intuitive, expressive, and fun,” said Luke Lin, CEO of Linkind. “By combining in-app AI with the creative power of ChatGPT, we’re giving users more ways than ever to shape their environment with light.”

Dotis and Dotis+ are available now in app versions 2.12.0 and later on both iOS and Android. Dotis and Dotis+ can be used with the following Linkind lighting devices.

Compatible Models and Purchase Options

About Linkind

Linkind, a brand of AiDot, is passionate about lighting your spaces in intelligent and meaningful ways, all while adopting the dedication to innovation and eco-conscious design instilled by its parent company, and overall ecosystem, AiDot. These tenants have guided Linkind from the start and are why they are now able to proudly offer solutions to match any and all residential scenes, such as smart solar-powered solutions that light the path to your home, TV backlighting that takes movie night to the next level, and easy-to-use everyday lighting with unmatched levels of user convenience. Linkind is lighting the way to a brighter tomorrow.

NEW YORK, Sept. 12, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on September 12th

• Equities are mixed Friday morning after stocks rallied to a fresh record on Thursday. The DOW closed above 46,000 for the first time ever, while the S&P 500 climbed by over 0.8%.
• The August Consumer Price Index revealed prices rose by 2.9% year-over-year in line with expectations. Then, signs of a cooling labor market persisted, with initial weekly jobless claims reaching 263,000.
• IPOs at the NYSE continue as Via Transportation rings the Opening Bell and begins trading later today. Via, which works with cities and governments to transform public transit with technology, priced its IPO above range at $46 per share.

Opening Bell
Via Transportation (NYSE: VIA) celebrates its IPO

Closing Bell
IONQ (NYSE: IONQ) marks its 2025 Analyst Day

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2771913/NYSE_Market_Update_Sept_12.mp4